The landscape of dementia prognosis has advanced substantially with the advent of subtle biomarkers, together with amyloid PET scans, tau imaging, and blood-based mostly tests that could detect Alzheimer's pathology many years right before signs and symptoms arise. While these technological advancements stand for exceptional development in being fa